Pharmaceuticals

Concept Medical is Granted CE Certification for Their Sirolimus Coated MagicTouch Group of Products

Concept Medical B.V. with its headquarters in Tampa, Florida has announced that on16th October 2019, they have received the CE certification for their MagicTouch group of products. HOEVELAKEN, Netherlands, Oct. 18, 2019 /PRNewswire/ -- The CE certified products/brands are as listed below: * M...

2019-10-18 10:07 278

Envirotainer Opens RAP e2 Station in Liege (LGG)

UPPLANDS VASBY, Sweden, Oct. 17, 2019 /PRNewswire/ -- Envirotainer, the global market leader in secure cold chain solutions for air transport of pharmaceuticals, today announced that they are upgrading their network of stations supporting their state-of-the-art e-technology container, the RAP e2,...

2019-10-17 14:39 241

Curiox Biosystems Achieves Commercialisation and Fund Raising Success in North Asia with the Support of Cornerstone Investor, ZIG Ventures

* CURIOX BIOSYSTEMS, is an A*STAR spinoff company, that develops bioinstrumentation solutions used in cell analysis and therapy for the pharmaceutical and biotech industries. The company has successfully penetrated theUSA, PRC, Korean and European markets and also secured a Series B funding of ...

2019-10-16 07:00 340

Movilitas Announces Featured Speakers for Track and Trace Conference in Kuala Lumpur

Conference's key themes include emerging regulations for serialization and traceability, challenges for different stakeholders of the life science industry, the role of GS1 standards and best-in-class practices COLUMBIA, Maryland, Oct. 16, 2019 /PRNewswire/ -- Movilitas, a technology leader deli...

2019-10-16 04:11 330

Systech Expands Market-Leading Brand Protection Solution for Improved Supply Chain Visibility

PRINCETON, New Jersey, Oct. 15, 2019 /PRNewswire/ -- Systech, a global technology leader in digital brand protection and product authentication, today announced a new release of theSystech Brand Protection Suite™—its fully integrated platform to combat counterfeiters, solve product diversion and ...

2019-10-15 21:00 291

Data Presented at 3rd Healthy Lung Summit 2019, Demonstrates Impact of AstraZeneca's Healthy Lung Partnership Programme in 9 Asian Countries

JAKARTA, Indonesia, Oct. 15, 2019 /PRNewswire/ -- Building on the continued success of the Healthy Lung Programme, today AstraZeneca and Business Sweden - The Swedish Trade & Invest Council host the 3rd Heathy Lung Summit, bringing together the Healthy Lung Taskforces from eight Asian countries a...

2019-10-15 16:17 2369

Admedus Inks $A36.2M Deal for CardioCel And VascuCel Patch Business

Transaction Highlights: * Admedus has sold the distribution rights to its CardioCel® and VascuCel® product range for$A36.2 million (including all earnouts) to LeMaitre Vascular Inc. * $A22.8M upfront payment plus two instalments of $A1m each after 12 months and 36 months * Up to $A11.4M on...

2019-10-14 12:51 446

CMAB Biopharma and BJ Bioscience Establish an Exclusive Strategic Partnership

* The new partnership will combine the research and development ingenuity of BJ Bioscience with the state-of-art biologics manufacturing set up of CMAB * CMAB will provide full development and manufacturing services for BJ Bioscience's BJ-005 bi-functional antibody * BJ-005 is planned to ent...

2019-10-11 18:00 1339

Bayer G4A Partners With Wellthy Therapeutics

MUMBAI, India, Oct. 11, 2019 /PRNewswire/ -- Wellthy Therapeutics, South Asia's leading digital therapeutics (DTx) company today announced its partnership with Bayer (BAYN: DE) through its G4A partnership initiative. Wellthy Therapeutics stands out as onefrom over 750 digital health companies spr...

2019-10-11 09:00 702

MabPlex Lauded by Frost & Sullivan for Global Expansion of ADC Contract Manufacturing Services

YANTAI, China, Oct. 10, 2019 /PRNewswire/ -- Based on its recent analysis of the global antibody drug conjugate (ADC) contract manufacturing services market, Frost & Sullivan recognizesChina-based MabPlex International, Ltd (MabPlex) with the 2019 Global Growth Excellence Leadership Award. MabPle...

2019-10-10 21:00 422

Innovent and Chi-Med Expand Global Collaboration to Evaluate the Combination of Sintilimab and Surufatinib in Solid Tumors

SUZHOU, China and LONDON, Oct. 10, 2019 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801) and Hutchison China MediTech Limited ("Chi-Med") (AIM/Nasdaq: HCM) today announced the expansion of their global collaboration agreement to evaluate the safety and efficacy of Innovent's Ty...

2019-10-10 15:55 1220

CTFH and Insilico Medicine Enter Al Drug Discovery Collaboration Focused On Accelerating First-in-Class Therapeutics, Worth Up to $200 million

HONG KONG and NANJING, China, Oct. 9, 2019 /PRNewswire/ -- Insilico Medicine, a company developing an end-to-end drug discovery pipeline utilizing the latest advances in deep learning, has entered into a two-program AI drug discovery collaboration agreement with Jiangsu Chia Tai Fenghai Pharmaceu...

2019-10-09 20:58 463

Datar Cancer Genetics Announces Positive Results With 42.9% Objective Response Rate, and 90.5% Disease Control Rate in Heavily Pre-treated Patients With Ultra-personalised Pan-cancer Treatment Protocol in the RESILIENT Trial

LONDON, MUMBAI, India and BAYREUTH, Germany, Oct. 9, 2019 /PRNewswire/ -- - RESILIENT Protocol captures Encyclopedic information from tumors and uses Artificial Intelligence (AI) to optimize treatments; - Objective Response and Disease Control Comparable to or better than most Immunotherapy opti...

2019-10-09 17:56 756

World Thrombosis Day Empowers People Around the World to Recognize and Help Prevent Life-Threatening Blood Clots

In Its Sixth Year, the Global Campaign Highlights Ways to Reduce the Impact of a Condition that Contributes to One in Four Deaths Worldwide CHAPEL HILL, North Carolina, Oct. 9, 2019 /PRNewswire/ -- On October 13, the World Thrombosis Day campaign shares an important message: patients, regardless ...

2019-10-09 12:00 313

Tim Oldham Appointed as Chief Executive Officer of AdAlta Ltd

* Experienced Pharmaceutical Executive * Decades of global business development, strategy and biologic drug development experience * Expertise to drive the next phase of AdAlta's growth MELBOURNE, Australia, Oct. 9, 2019 /PRNewswire/ -- The Board of AdAlta Limited (ASX:1AD), is pleased to a...

2019-10-09 09:42 489

Breast Cancer: Hormone Therapy Has a Bigger Impact Than Chemotherapy on Women's Quality of Life - Research by Institut Gustave Roussy

PARIS, Oct. 9, 2019 /PRNewswire/ -- Analysis of the CANTO cohort published in the journalAnnals of Oncology will upset received wisdom on the effects that hormone therapy and chemotherapy have on the quality of life in women with breast cancer. Contrary to ...

2019-10-09 07:00 314

Chipscreen and Novogene enter a strategic partnership for companion diagnostics development

SHENZHEN, China, Oct. 8, 2019 /PRNewswire/ -- Chipscreen Biosciences Co., Ltd. (Chipscreen, Stock Symbol: 688321.SH) and Novogene Co., Ltd. (Novogene) recently announced a strategic partnership for companion diagnostics (CDx) development. Under the agreement, Novogene will develop a CDx for Chips...

2019-10-08 20:46 422

Drugstore Chain Mik Japan Launches International "Samurai Drugstore" Online Store with USD 100,000 Point-Back Campaign

OSAKA, Japan, Oct. 8, 2019 /PRNewswire/ -- Established 48 years ago in Japan, Mik Japan Co., Ltd. (Head office:Osaka, Japan. President: Eiji Usui), a drugstore chain managing over 50 outlets, has opened Samurai Drugstore, an international online store for drugstore products fromJapan. The company...

2019-10-08 14:00 348

Ascletis Appoints Former Novartis Global Head Dr. Handan He as Chief Scientific Officer

HANGZHOU, China and SHAOXING, China, Oct. 8, 2019 /PRNewswire/ -- Ascletis Pharma Inc. (1672.HK), an innovative R&D driven, commercial-stage biotechnology company addressing unmet medical needs in therapeutic areas including anti-viral, cancer and fatty liver diseases, announces today that Dr.Han...

2019-10-08 08:00 444

Innovent Biologics Announces a New Placement Raised HK$2,351.33 Million

SUZHOU, China, Oct. 4, 2019 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent" or "the Company") (HKEX: 01801), a world-class biopharmaceutical company that develops and commercializes high quality medicines for the treatment of oncology, autoimmune, metabolic and other major diseases, announc...

2019-10-04 16:11 792
12345 ... 58